A Case Study of Amul: Implementation of Extension Strategy to Repositioning Brand During Covid-19 Period
International Journal of Emerging Research in Engineering, Science, and Management · 2022
DOI: 10.58482/ijeresm.v1i4.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Emerging Research in Engineering, Science, and Management, 2022. Verfasst von Dr. A. B. Mishra und 2 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
During lockdown and consequent pandemic, many organizations reduced their production, and few shut their operations. Some organizations continued their regular production. Apart from Pharma, very few organizations raised their production and raised their sales. Amul, a dairy products company is the one which in addition to raising production and sales, established an emotional and social connection with their clients. The advantage of essential commodity category and milk production aided its success during the pandemic. In this paper, the marketing strategy of Amul is review as backbone of their success being the advertising strategy.
Zitieren
APA
Mishra, D. A. B., Goel, M. A., & Jajoo, M. P. (2022). A Case Study of Amul: Implementation of Extension Strategy to Repositioning Brand During Covid-19 Period. International Journal of Emerging Research in Engineering, Science, and Management. https://doi.org/10.58482/ijeresm.v1i4.3
Vancouver
Mishra DAB, Goel MA, Jajoo MP. A Case Study of Amul: Implementation of Extension Strategy to Repositioning Brand During Covid-19 Period. International Journal of Emerging Research in Engineering, Science, and Management. 2022. doi:10.58482/ijeresm.v1i4.3
BibTeX
@article{Mishra2022,
author = {Mishra, Dr. A. B. and Goel, Ms. Anmol and Jajoo, Ms. Pooja},
title = {A Case Study of Amul: Implementation of Extension Strategy to Repositioning Brand During Covid-19 Period},
journal = {International Journal of Emerging Research in Engineering, Science, and Management},
year = {2022},
doi = {10.58482/ijeresm.v1i4.3}
}
EUVIMED